Annual report pursuant to Section 13 and 15(d)

Equity (Tables)

v3.3.1.900
Equity (Tables)
 12 Months Ended
Dec. 31, 2015
Equity [Abstract]  
Schedule of Proceeds from Initial Public Offering

The transaction was recorded at the value of the net proceeds. The expenses related to this public offering are as follows:

 

    $     $
Gross Proceeds:           14,998,500
Underwriter/Aegis Expenses            
Underwriter Commission     1,049,895      
Underwriter Expenses     149,985      
Aegis Legal Fees     80,000      
Aegis Registration Expenses     7,500      
Aegis Miscellaneous Expenses     36,675      
Aegis Road Show Expenses     20,000      
Total           1,344,055
Akers Biosciences Expenses            
Legal & Accounting Expenses     393,298      
Printing & Document Prep     62,101      
Registration Expenses     55,946      
Road Show Expenses     41,764      
Total           553,109
Net Procceds:           13,101,336

Schedule of Reserved Shares of Common Stock

As of December 31, 2015 and 2014 the Company has reserved shares of its common stock as follows:

 

    2015     2014  
Reserves for:                
 Outstanding Warrants     -       1,989  
 2013 Stock Incentive Plan     220,500       175,000  
Total Reserves     220,500       176,989  

Schedule of Reconcilement of the Movement of Shares

The following is a reconcilement of the movement of shares of Series A Convertible Preferred stock (preferred stock) and common stock:

 

    Authorized     Issued  
    Preferred     Common     Preferred     Common  
    Stock     Stock     Stock     Stock  
Balance at December 31, 2013   50,000,000     500,000,000     -     2,167,837  
                                 
Shares Issued:                                
January 23, 2014     -       -       -       2,727,000  
August 15, 2014     -       -       -       60,000  
Balance at December 31, 2014     50,000,000       500,000,000       -       4,954,837  
                                 
Shares Issued:                                
January 9, 2015     -       -       -       190,000  
December 29, 2015     -       -       -       280,208  
Balance at December 31, 2015     50,000,000       500,000,000       -       5,425,045